A Systematic Review and Meta-analysis of Association between Serum Vitamin D and Atopic Dermatitis
Abstract
Objective: The relationship between vitamin D and atopic dermatitis remains controversial. Here, we systematically reviewed and meta-analyzed the association between serum 25-hydroxy vitamin D concentration (25(OH)D) and atopic dermatitis (AD), AD severity, and the benefits of oral vitamin D supplementation.
Methods: A total of 15 observational studies and 5 RCTs from 12 countries were included in this review. The effects of vitamin D deficiency or vitamin D level on AD and standardized AD severity score were performed using a random-effects model on 3 aspects: 1) serum vitamin D and risk of AD, 2) serum vitamin D level and severity of AD, and 3) the benefits of oral vitamin D supplementation on AD severity.
Results: The analysis showed serum 25(OH)D deficiency marginally increased the risk of AD (OR = 1.55, 95%CI = 0.94 - 2.55, p = 0.084). Low serum 25(OH)D was correlated with greater AD severity (r = -0.29, 95%CI = -0.504 to -0.048, p = 0.020), and oral vitamin D supplementation helped reduced AD severity score by 0.963 standard deviation (95%CI = 0.23 to 1.70, p = 0.011).
Conclusion: The association between serum 25(OH)D deficiency and risk of AD was still controversial. However, our meta-analysis suggested that higher serum 25(OH)D is associated with lower severity of AD. Moreover, oral vitamin D supplementation also helps to reduce AD severity.
Keywords: Atopic dermatitis, vitamin D, systematic review, meta-analysis
Downloads
Published
How to Cite
Issue
Section
License
Users are free to share, copy, and redistribute all articles published in the Siriraj Medical Journal (SMJ) in any medium or format as long as you follow the following terms:
- Attribution — You must give appropriate credit, provide a link to the material, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the publisher endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.